Reliant Challenges Abbott's TriCor Patents

Law360, New York (June 4, 2004, 12:00 AM EDT) -- Reliant Pharmaceuticals Inc. has filed a lawsuit against Abbott Laboratories, asking a federal judge to invalidate four anti-cholesterol drug patents.

In a suit filed in U.S. District Court for the District of Delaware last week, Reliant says it plans to sell a version of Abbott's TriCor capsules, and that it expects Abbott and the original patent owner, Laboratoires Fournier of France, to sue for patent infringement.

The patents for the drug are unenforceable because the inventors failed to tell the U.S. Patent and Trademark Office about...
To view the full article, register now.